The Loncar Cancer Immunotherapy Index

The Loncar Cancer Immunotherapy Index aims to track the performance of the transformative therapy sector within the biotechnology industry. Biotech stocks are often grouped together as a whole, but areas such as immunotherapy have their own unique environment and innovation. The goal of the Cancer Immunotherapy Index is to provide investors with a better understanding of the immunotherapy industry by highlighting key relevant companies and offering metrics to track their progress. It aims to emphasize that immunotherapy will lead to increased awareness within the investment community, boost investment in the field, and bring more advancements for patients battling cancer.